Peptide Referee

ACE-031: research, legal status and who sells it

This page is information, not medical advice. ACE-031 is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.

Category
Soluble activin receptor IIB fusion protein
Evidence level
Early human trials
Price range
$29.99/mg to $161.00/mg, median $109.45/mg across 7 vendors (compare)
Our lab tests
None yet (how testing will work)
WhereStatus
United StatesNo FDA-approved drug contains ACE-031 [1].
United KingdomNo UK-licensed medicine containing ACE-031 appears in the MHRA products database [2].
European UnionNo medicine containing ACE-031 is authorized in the EU, according to EMA's central and Article 57 product data [3][4].
CanadaNo product containing ACE-031 appears in Health Canada's Drug Product Database [5].
AustraliaACE-031 is not named in Australia's Poisons Standard (October 2026) [6].
Sport (WADA)Named as a prohibited decoy activin receptor under S4 [7].
 Summaries of official sources, checked —. Rules change; follow the source links. Not legal advice.

We haven't published a full overview of ACE-031 yet. The legal status table and live prices on this page are current.

ACE-031 prices: cheapest listings

The five lowest $/mg listings out of 8. See all ACE-031 prices

Vendor Transparency Product Size Price $/mg vs median Stock Vendor's page
Geo Peptides 52/100 ACE-031 1mg (ACVR2B) 1 mg $30 $29.99/mg −73% — View
Peptides Warehouse 62/100 ACE-031 1mg 1 mg $38 $37.59/mg −66% In stock View
Volta Peptides 70/100 ACE-031 1mg 1 mg $74 $74.00/mg −32% Out of stock View
Pure Peptide Labs 90/100 ACE-031 1 mg $80 $79.95/mg −27% In stock View
Swiss Chems FDA warning letter, Dec 2024 72/100 ACE-031 1 mg 1 mg × 10 $1,390 $138.95/mg +27% Out of stock View

Prices come from each vendor's public product feed and were last fetched Oct 15, 2026. They exclude shipping and discounts. $/mg uses the labeled amount, not measured content. How we compare prices.

Sources

  1. Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 14, 2026
  2. MHRA Products: licensed-medicine search for "ramatercept". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
  3. EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 14, 2026
  4. EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 14, 2026
  5. Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 14, 2026
  6. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 14, 2026
  7. World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 14, 2026